Suzanne Angell
Suzanne Angell is Director of Therapeutics Research at Casdin Capital, a role she has held since joining the firm in 2012. She has over 16 years of business and investment management experience across multiple platforms.
What Suzanne can write
Career
- Cooper Hill Partners · research analyst
- Alpine ESD · managing director and advisor
- C. Kenneth Imports · managing director and advisor
- Jungell · chief operating officer and chief financial officer
- Casdin Capital · Director of Therapeutics ResearchNow
Focus
Education
Also at Casdin Capital
Partners like Suzanne
At firms with a similar stage, sector and check size.
Alert me when Casdin Capital is active
One email when Suzanne's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Suzanne Angell?
Suzanne Angell is Director of Therapeutics Research at Casdin Capital, a role she has held since joining the firm in 2012. She has over 16 years of business and investment management experience across multiple platforms.
How much does Suzanne Angell invest?
Casdin Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.
How do I pitch Suzanne Angell?
Email [email protected], the firm's inbox for founders, and name Suzanne in the subject. A warm intro from a founder Casdin Capital backed works better.
What did Suzanne Angell do before Casdin Capital?
research analyst at Cooper Hill Partners; managing director and advisor at Alpine ESD; managing director and advisor at C. Kenneth Imports; chief operating officer and chief financial officer at Jungell.
Last updated 2026-10-15. Is this you? Ask for a correction.